Table 3.
Intervention/Model | Diabetes Model | ROS/Oxidative Stress | Cardiac Structure/Function | Author |
---|---|---|---|---|
MnSOD-TG | OVE26 T1D mice genetic lipid overload-induced T2D mice | ↑ cardiac SOD activity ↑ mitochondrial MnSOD protein ↑ CAT protein/activity, GSH protein ↓ cardiomyocyte ROS ↓ mitochondrial H2O2, 4-HNE |
↑ RCR, state 3 respiration ↓ mitochondrial mass/number; ↑ mitochondrial function ↑ CM contractility ↓ mitochondrial size ↑ mitochondrial fission |
Shen [31] Tsushima [89] |
CM-specific CAT-TG | STZ-induced T1D mice OVE26 T1D mice | ↓ ROS, H2O2, MPO, 3-NT of α-KGD, ATP-α and ATP-β ↓ iNOS protein; ↔ eNOS protein ↑ SIRT2 protein ↓ MDA; CM ROS |
↓ systolic & diastolic cardiac dysfunction ↓ CM contractile dysfunction ↓ LV hypertrophy ↓ myocardial disorder ↓ cardiac fibrosis, apoptosis ↓ mitochondrial damage ↑ CM contractility |
Cong [182], Turdi [183] Ye [29] |
mPHGPx-TG | STZ-induced T1D mice | ↓ H2O2 production, 4-HNE, MDA in IFM | ↓ systolic dysfunction ↑ ATP synthase activity in IFM ↑ mitochondrial respiration ↓ mitochondrial dysfunction |
Baseler [185] |
GSHPx-TG | STZ-induced T1D mice | ↓ TBARS, 4-HNE ↑ GSH-Px; ↔ SOD, CAT activities |
↓ CM hypertrophy ↓ fibrosis ↓ apoptosis |
Matsushima [186] |
TRX2 activation or TRXR inhibitors, Auranofin & CDNB | STZ-induced T1D mice | ↓ ROS ↓ PRX-SO2/3H; ↔ TRX1 expression/localization |
↓ CM hypertrophy ↓ contractile dysfunction |
Li [190] |
CM-specific TXNIP KO | STZ-induced T1D mice | ↔ ROS | ↔ LV hypertrophy, cardiac function ↑ inotropic reserve |
Myers [194] |
GSH precursor, NAC | STZ-induced T1D mice | ↓ ROS, H2O2, TAS, NO ↑ GSH content |
↓ systolic & diastolic dysfunction ↓ LV hypertrophy ↓ fibrosis, apoptosis ↑ myofilament morphology |
Liu [199], Fiordaliso [200], Yildirim [201] |
CM-specific MT-TG | OVE26 T1D mice STZ-induced T1D mice | ↓ GSSG; ↔ GSH ↓ , ROS, 3-NT; 3-NT of ATP synthase α ↓ Trp374/Tyr135 nitration of SCOT ↑ p47(phox) |
↓ myocardial injury ↓ CM contractile dysfunction; LV dysfunction/stiffness ↓ myocardial structural derangement ↓ fibrosis, necrosis ↑ ATP synthase, SCOT activity |
Liang [50] Wold [113], Cai [264], Cong [213], Cong [214] |
SIRT3 KO mice | STZ-induced T1D mice | ↑ ROS | ↑ cardiac dysfunction ↑ necrosis ↓ ATP |
Song [223] |
NRF2 KO | STZ-induced T1D mice HFD/STZ-induced T2D mice | ↑ 8-OHdG, MDA, 3-NT, 4-HNE ↓ NRF2, NQO1 mRNA ↑ ROS production ↓ NRF2, NQO1, HO1 mRNA/protein ↓ total, nuclear NRF2 protein ↑ 8-OHdG, MDA ↓ NQO-1, HO-1, MT mRNA; MT protein |
↓ cardiac dysfunction ↓ CM hypertrophy, myocardial structural damage ↓ CM contractility ↑ fibrosis, apoptosis ↑ CM hypertrophy ↓ systolic function ↑ fibrosis |
He [257], He [237], Zang [301] Gu [239] |
CM-specific NRF2-TG mice | STZ-induced T1D mice | ↑ 4-HNE, 8-OHdG | ↑ cardiac dysfunction ↑ fibrosis, apoptosis |
Zang [301] |
NRF2 activator, Dh404 | STZ-induced T1D mice | ↑ NRF2 protein ↓ 3-NT |
Tan [233] | |
HO-1-TG mutHO-1-TG | STZ-induced T1D mice | HO-1-TG: ↓ p47phox, GSH-PX3 mRNA) mutHO-1-TG: ↑ p47phox, GSH-Px3 mRNA | HO-1-TG: ↓ systolic dysfunction mutHO-1-TG: ↑ apoptosis | Zhao [240] |
ALDH2-TG | sucrose-fed pre-T2D mice | ↑ SIRT3, HO-1 protein ↓ ROS |
↓ myocardial dysfunction ↑ CM contractility ↑ intracellular Ca2+ handling ↑ NAD + activity |
Hu [252] |